It has been a significant time since a product from The Ordinary was reviewed, and this particular item was the first one that genuinely sparked interest. The Multi-Peptide Lash and Brow Serum was acquired in December 2022 from Sephora PH, during a period when a holiday limited edition featuring their lash and brow serum in a duo pack was available. This serum is formulated as a light, non-greasy solution specifically designed to promote the appearance of thicker, fuller, and healthier-looking lashes and brows.
Product Description and Application
The Multi-Peptide Lash and Brow Serum is presented in a slender, plastic tube containing 5ml of product. It features a thin, wispy, brush-like applicator for precise application. The serum itself is clear and has a watery-thin consistency, devoid of any discernible scent. A single tube typically lasts for approximately 6 months, making the duo pack sufficient for a year of use.
Key Ingredients and Their Functions
This serum boasts a sophisticated blend of various peptides, each belonging to distinct complexes designed to target lash and brow enhancement:
- SymPeptide XLash: Contains the peptide Myristoyl Pentapeptide-17, which is purported to improve the appearance and density of eyelashes.
- Anargy Complex: This complex includes Oligopeptide-2 along with biopeptides. These components work to nourish and protect the hair root, aiding in the reactivation of the hair growth cycle.
- Widelash Complex: Features Biotinoyl Tripeptide-1 combined with panthenol. This combination is known to encourage the proliferation of cells within the hair bulb, thereby ensuring 'optimal hair anchorage'.
- Redensyl Complex: Comprising ingredients such as Larix Europaea Wood Extract, Green Tea Leaf Extract, and Zinc Chloride, this complex has demonstrated the ability to enhance hair growth by stimulating hair follicles.
- Capixyl Complex: This complex has been shown to contribute to fuller and thicker eyelashes by purportedly stimulating hair growth while simultaneously preventing hair loss. It contains Acetyl Tetrapeptide-3, along with butylene glycol, water, dextran, and clover flower extract.
Personal Experience and Results
The user's experience involved before-and-after photos that were not taken precisely 4 weeks apart. Initially, after a month of use, there was a perceived lack of significant results, leading to a delayed 'after' photo taken approximately 4 months post-application. Upon reviewing these photos, particularly those focused on the lashes, a noticeable difference became apparent.
While the serum did not appear to lengthen the lashes or brow hairs, the visual evidence suggested an improvement in fullness and density. A significant observation was a marked reduction in hair shedding from both lashes and brows. Previously, when removing waterproof eye makeup, it was common to find lash or brow hairs on cotton pads. This reduced shedding indicates that the hair strands have become stronger.
Usage Duration and Future Purchase Considerations
As of the time of writing, the serum had been completely used up, with the last application occurring near the end of 2023. The decision not to repurchase immediately was driven by a desire to assess the longevity of the achieved effects on lashes and brow hairs. The availability of the serum also presents a challenge, as it is not readily accessible in the user's location, and The Ordinary has reportedly ceased its presence at Sephora PH.
The current retail price for a single tube of this serum is $14.90. The duo pack was purchased for Php850, which converts to approximately $15.21 at the current exchange rate.
Conclusion
The Multi-Peptide Lash and Brow Serum from The Ordinary offers a compelling formulation with a variety of peptides aimed at enhancing lash and brow appearance. While initial results may not be immediately apparent, consistent use over several months can lead to noticeable improvements in density, fullness, and a reduction in hair shedding, suggesting stronger hair strands. Availability and personal experience will ultimately influence repurchase decisions.